About Prostaglandin E2 receptor EP2 subtype
Prostaglandin E2 receptor EP2 subtype (PTGER2) is a protein
from Homo sapiens identified by UniProt accession
P43116, 358 residues long.
MolForge cross-references it against 0 known binders and
199 disease associations.
Target properties
| Protein name | Prostaglandin E2 receptor EP2 subtype |
| UniProt accession | P43116 |
| Gene | PTGER2 |
| Organism | Homo sapiens |
| Length | 358 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (199)
Diseases linked to this target (Open Targets).
- erectile dysfunction · score 0.56
- pregnancy · score 0.46
- Premature rupture of membranes · score 0.46
- myocardial infarction · score 0.46
- pain · score 0.43
- cardiovascular disease · score 0.38
- ocular hypertension · score 0.37
- open-angle glaucoma · score 0.37
- stroke · score 0.37
- ischemia · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P43116-F1 | alphafold | PREDICTED | 77.57 | — |
Amino-acid sequence (358 residues)
MGNASNDSQS EDCETRQWLP PGESPAISSV MFSAGVLGNL IALALLARRW RGDVGCSAGR RSSLSLFHVL VTELVFTDLL GTCLISPVVL ASYARNQTLV ALAPESRACT YFAFAMTFFS LATMLMLFAM ALERYLSIGH PYFYQRRVSR SGGLAVLPVI YAVSLLFCSL PLLDYGQYVQ YCPGTWCFIR HGRTAYLQLY ATLLLLLIVS VLACNFSVIL NLIRMHRRSR RSRCGPSLGS GRGGPGARRR GERVSMAEET DHLILLAIMT ITFAVCSLPF TIFAYMNETS SRKEKWDLQA LRFLSINSII DPWVFAILRP PVLRLMRSVL CCRISLRTQD ATQTSCSTQS DASKQADL
Explore Prostaglandin E2 receptor EP2 subtype with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets